Growth Factor Signaling BPC-157 enhances the activity of multiple growth factors, including VEGF (vascular endothelial growth factor), TGF- (transforming growth factor beta), and FGF (fibroblast growth factor)
In September 2023, the FDA added injectable GHK-Cu to a list of compounded substances considered high-risk due to limited safety data
They act as signaling molecules, directing cells and tissues to perform specific functions such as healing, repairing, regulating inflammation, and even improving energy production
This heightened OS can potentially change the activity and structure of vital cellular macromolecules, such as DNA, leading to abnormal cell growth, mutation, and/or chromosome instability
However, its effectiveness in targeting deep belly fat, improving IGF-1 levels, and preserving lean tissue has made it increasingly popular in performance, bodybuilding, and anti-aging circles